Company profile: Ion Torrent
1.1 - Company Overview
Company description
- Provider of sequencing technology that enables a direct connection between chemical and digital information; the first commercial PostLight sequencing technology that doesn't use light. Ion Torrent is a wholly-owned subsidiary of Life Technologies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ion Torrent
Isobionics
HQ: The Netherlands
Website
- Description: Provider of isoprenoid-based flavor and fragrance ingredients produced via a proprietary biotechnology process for the food, beverage, flavor and fragrance markets, delivering higher quality and purity at lower production cost. Portfolio includes Natural Nootkatone, beta-Caryophyllene, Valencene, (-)-alpha-Bisabolol, alpha-Bisabolene, and beta-Bisabolene.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Isobionics company profile →
StatLab
HQ: United States
Website
- Description: Provider of diagnostic supplies for the anatomic pathology lab market, developing and manufacturing cost-effective histology, cytology, and immunohistochemistry products. Offerings include large-format tissue processing cassettes, histology reagents, slides and cassettes, paraffin embedding wax, cytology collection devices, fixatives, stains, accessories, and microbiology consumables such as sterile, control, and printed diagnostic slides.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full StatLab company profile →
Cell Microsystems
HQ: United States
Website
- Description: Provider of single-cell biology products, including the CellRaft AIR System for single-cell/colony culture; BioFlux Systems to emulate in vivo shear flow for drug discovery and cell analysis; CERO 3D Incubator & Bioreactor for organoid, spheroid, and tissue research; CASY Cell Counter & Analyzer for cell counting and viability without dyes or reagents; TIGR Tissue Grinder & Dissociator; and IonFlux Mercury Systems for ion channel research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cell Microsystems company profile →
Immunicom
HQ: United States
Website
- Description: Provider of patented Immunopheresis blood-filtering technology that removes specific blood factors to enable the immune system to fight certain cancers; the LW-02 investigational therapeutic cartridge; the EN-06 cartridge in pre-clinical development; and clinical trials at leading hospitals evaluating LW-02 for triple-negative breast cancer, non-small cell lung cancer, melanoma, and renal cell carcinoma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunicom company profile →
InSphero
HQ: Switzerland
Website
- Description: Provider of organotypic biological in vitro 3D microtissues and microtissue-based assays for biochemical compound screening and predictive drug testing, offering human prostate and mammary carcinoma and rat liver microtissues, plus services including compound toxicity testing, cell-invasion assays, and stem-cell research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InSphero company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ion Torrent
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ion Torrent
2.2 - Growth funds investing in similar companies to Ion Torrent
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ion Torrent
4.2 - Public trading comparable groups for Ion Torrent
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →